Germany’s Merck has agreed to acquire London-based Silence Therapeutics in an all-cash deal, adding a late-stage rare blood ...

Estuary Biotherapeutics launches with $103 million to take gene therapies for kidney disease into the clinic. The financing ...

Labcorp acquires BioReference Health assets from OPKO for $722 million, expanding reach of its FDA-approved 4Kscore prostate ...

The clinical-stage biotech has closed an oversubscribed Series D financing round in a bid to meeting its mission to stop ...

Biopharma finance leaders detail how they build and refine gross-to-net models amid shrinking margins across biopharma ...

AstraZeneca pays $40 million upfront to put insitro's AI platform to work on metabolic dysfunction-associated steatohepatitis ...

Zealand Pharma has signed a multi-target collaboration with Generate Biomedicines to design protein therapeutics for obesity ...

Sponsors trialing drugs in the European Union (EU) will be able to continue seeking input from the European Medicines Agency ...

The regulatory professional then does what only they can do; apply scientific and legal judgment, validate the AI's reasoning ...

Study finds Bluesky and X users share clinical trial information differently, which could impact recruitment strategies ...

The collaboration will integrate AI more directly into scientific instrumentation, aiming to close the gap between ...

IgniteData and RealTime eClinical Solutions partner to let RealTime's clinical research sites use IgniteData's Archer ...